Bonaventura Clotet to Middle Aged
This is a "connection" page, showing publications Bonaventura Clotet has written about Middle Aged.
Connection Strength
0.111
-
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients. J Antimicrob Chemother. 2018 03 01; 73(3):732-737.
Score: 0.012
-
Aging in HIV-Infected Subjects: A New Scenario and a New View. Biomed Res Int. 2017; 2017:5897298.
Score: 0.012
-
Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice. Br J Clin Pharmacol. 2007 Jun; 63(6):715-21.
Score: 0.006
-
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):47-52.
Score: 0.005
-
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance. 2021 09; 4(9).
Score: 0.004
-
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
Score: 0.004
-
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. Lancet Infect Dis. 2021 10; 21(10):1365-1372.
Score: 0.004
-
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021 05; 21(5):629-636.
Score: 0.004
-
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
Score: 0.004
-
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. N Engl J Med. 2021 02 04; 384(5):417-427.
Score: 0.004
-
Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series. Clin Microbiol Infect. 2021 Apr; 27(4):651-652.
Score: 0.004
-
NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV. J Assoc Nurses AIDS Care. 2019 Jan-Feb; 30(1):35-41.
Score: 0.003
-
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS. 2018 10 23; 32(16):2405-2416.
Score: 0.003
-
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs. J Antimicrob Chemother. 2018 09 01; 73(9):2452-2459.
Score: 0.003
-
Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up. Int J STD AIDS. 2019 01; 30(1):56-63.
Score: 0.003
-
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 01; 12(1):232-246.
Score: 0.003
-
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat Commun. 2018 07 16; 9(1):2739.
Score: 0.003
-
High Prevalence of Sarcopenia in HIV-Infected Individuals. Biomed Res Int. 2018; 2018:5074923.
Score: 0.003
-
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial. J Antimicrob Chemother. 2018 07 01; 73(7):1965-1971.
Score: 0.003
-
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. J Antimicrob Chemother. 2018 07 01; 73(7):1940-1948.
Score: 0.003
-
Recurrent coronary disease in HIV-infected patients: role of drug-drug interactions. Br J Clin Pharmacol. 2018 07; 84(7):1617-1619.
Score: 0.003
-
Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS One. 2017; 12(9):e0184433.
Score: 0.003
-
Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Sci Rep. 2017 09 15; 7(1):11711.
Score: 0.003
-
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS One. 2017; 12(8):e0182547.
Score: 0.003
-
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice. J Ultrasound Med. 2018 Jan; 37(1):113-121.
Score: 0.003
-
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death. PLoS One. 2017; 12(1):e0166613.
Score: 0.003
-
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial. J Antimicrob Chemother. 2015 Apr; 70(4):1139-45.
Score: 0.002
-
Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy. Virol J. 2013 Dec 05; 10:350.
Score: 0.002